BORDERLINE RESECTABLE/UNRESECTABLE PANCREATIC CANCER

Clinical trials for BORDERLINE RESECTABLE/UNRESECTABLE PANCREATIC CANCER explained in plain language.

Never miss a new study

Get alerted when new BORDERLINE RESECTABLE/UNRESECTABLE PANCREATIC CANCER trials appear

Sign up with your email to follow new studies for BORDERLINE RESECTABLE/UNRESECTABLE PANCREATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a measles vaccine fight pancreatic cancer? new trial aims to find out

Disease control Not yet recruiting

This early-phase study tests whether injecting the measles, mumps, and rubella (MMR) vaccine directly into pancreatic tumors is safe and can shrink them. About 20 adults with advanced, non-spreading pancreatic cancer that cannot be removed by surgery will receive the injection. R…

Matched conditions: BORDERLINE RESECTABLE/UNRESECTABLE PANCREATIC CANCER

Phase: PHASE1, PHASE2 • Sponsor: University of Arkansas • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

BORDERLINE RESECTABLE/UNRESECTABLE PANCREATIC CANCER

Get alerted when new BORDERLINE RESECTABLE/UNRESECTABLE PANCREATIC CANCER trials appear

Could a measles vaccine fight pancreatic cancer? new trial aims to find out